about
Emerging risk biomarkers in cardiovascular diseases and disordersMCP-1 Levels are Associated with Cardiac Remodeling but not with Resistant HypertensionMicroinflammation factors in the common diseases of the heart and kidneysPathological periodontal pockets are associated with raised diastolic blood pressure in obese adolescents.Differential and directional estrogenic signaling pathways induced by enterolignans and their precursors.Elevated Urinary T Helper 1 Chemokine Levels in Newly Diagnosed Hypertensive Obese ChildrenCardiometabolic Health in Submariners Returning from a 3-Month Patrol.Investigation of the functional role of human Interleukin-8 gene haplotypes by CRISPR/Cas9 mediated genome editingGenetic and Pharmacologic Inhibition of the Chemokine Receptor CXCR2 Prevents Experimental Hypertension and Vascular Dysfunction.A Novel Marker of Impaired Aortic Elasticity in Never Treated Hypertensive Patients: Monocyte/High-Density Lipoprotein Cholesterol Ratio.Heart selenoproteins status of metabolic syndrome-exposed pups: A potential target for attenuating cardiac damage.Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis.Monocyte Chemoattractant Protein-1 and Large Artery Structure and Function in Young Individuals: The African-PREDICT Study.Preserved endothelial progenitor cell angiogenic activity in African American essential hypertensive patients.Association between monocyte chemoattractant protein-1 and blood pressure in smokers.CX3CL1/CX3CR1 axis, as The Therapeutic Potential In Renal Diseases: Friend Or Foe?Relation between lymphocyte to monocyte ratio and short-term mortality in patients with acute pulmonary embolism.
P2860
Q28081614-E54D7F83-0FAC-4930-836E-391688A755DFQ33647436-7B835396-0E33-42F7-8C2C-C894697FBB2EQ35025893-D4D3CDC7-97E3-471D-AEF2-9FC99C6EF19CQ35216507-31CC0D9A-E48F-42DF-A67D-C4501E66B307Q36267739-49498796-DDE0-4712-B770-BA601C1A0F76Q36367765-1F379297-EFCB-4D9D-B92D-5935D5BB674FQ36633300-30DD30D8-D45F-4276-9963-560D6FC3CFE6Q37157449-4FACC25B-250F-47EF-8B64-92323CFFFF29Q37375207-3C9C6CE4-0016-47EC-B45D-FB1219A058F9Q37590767-2EFB3503-06B8-4C27-898B-06F8D253034DQ38831748-2AB3E140-AB78-45B8-B00E-0A7F39FAEC70Q39818605-4EB9E433-4811-42E6-A3A3-A3D7B6030A49Q46511773-C30DAD0D-678A-4841-883B-79EB722547C8Q46562954-D8C3A3DA-46DB-4D22-BE01-3C2370671B0CQ47446039-5A6A612C-AA14-49C6-BEEC-25457C076B8AQ49985968-26DA2DB1-9ED6-4876-9D33-E4F518D04805Q54322855-5ABA2BBE-CB74-4620-AAEF-6C86A6E88B35
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The role of chemokines in hypertension
@ast
The role of chemokines in hypertension
@en
The role of chemokines in hypertension
@nl
type
label
The role of chemokines in hypertension
@ast
The role of chemokines in hypertension
@en
The role of chemokines in hypertension
@nl
prefLabel
The role of chemokines in hypertension
@ast
The role of chemokines in hypertension
@en
The role of chemokines in hypertension
@nl
P2093
P3181
P356
P1433
P1476
The role of chemokines in hypertension
@en
P2093
Agnieszka Janus
Grzegorz Mazur
Helena Martynowicz
P304
P3181
P356
10.17219/ACEM/37123
P407
P577
2014-05-01T00:00:00Z